The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
Joseph H. Saunders
| Saunders and Walker

Congressman Henry Waxman (D-CA), Chairman of the House Committee on Oversight and Government Reform, has written a letter to the FDA requesting documents about their monitoring and evaluation of Medtronic’s Sprint Fidelis defibrillator. The Sprint Fidelis was voluntarily recalled after Medtronic disclosed that the Sprint Fidelis leads were prone to fracture causing defective operation of the defibrillator. The defect has been linked to five deaths thus far.

Specifically, the Congressman requested that the FDA provide the Congressional committee with evidence concerning its actions regarding approval of the device, a summary of the safety and effectiveness data which provided the basis for Sprint Fidelis’ approval, and information regarding when the FDA first learned of the defective defibrillator lead in the Sprint Fidelis.

Comments are closed.